锦波生物
(832982)
| 流通市值：55.36亿 | | | 总市值：159.31亿 |
| 流通股本：3075.59万 | | | 总股本：8851.18万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 225,500,687.12 | 780,260,212.25 | 517,043,663.93 | 316,329,891.18 |
| 营业收入 | 225,500,687.12 | 780,260,212.25 | 517,043,663.93 | 316,329,891.18 |
| 二、营业总成本 | 110,997,275.06 | 438,075,553.51 | 297,177,116.44 | 190,190,303.67 |
| 营业成本 | 18,272,718.26 | 76,779,035.2 | 51,883,437.16 | 34,334,071.71 |
| 税金及附加 | 1,524,841.1 | 8,184,220.09 | 5,773,261.01 | 4,220,605.48 |
| 销售费用 | 53,972,433.41 | 164,957,666.67 | 110,447,418.03 | 66,305,981.21 |
| 管理费用 | 24,450,782.55 | 92,246,148.04 | 59,362,692.46 | 38,571,088.06 |
| 研发费用 | 10,273,125.12 | 84,976,986.47 | 61,327,683.97 | 41,162,362.27 |
| 财务费用 | 2,503,374.62 | 10,931,497.04 | 8,382,623.81 | 5,596,194.94 |
| 其中:利息费用 | 2,631,732.58 | 11,061,810.14 | 8,483,743.25 | 5,540,368.57 |
| 其中:利息收入 | 236,613.48 | 637,612.87 | 404,720.79 | 193,284.48 |
| 加:投资收益 | 216,232.88 | 374,743.57 | 176,700.23 | -61,122.13 |
| 资产处置收益 | - | -8,955.04 | -310,095.8 | - |
| 资产减值损失(新) | -652,561.76 | -3,068,208.39 | -1,553,356.55 | -544,729.71 |
| 信用减值损失(新) | 327.49 | -4,205,842.47 | -3,098,696.1 | -3,586,416.13 |
| 其他收益 | 4,009,512.75 | 12,919,928.09 | 8,889,458.6 | 6,527,094.3 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 118,076,923.42 | 348,196,324.5 | 223,970,557.87 | 128,474,413.84 |
| 加:营业外收入 | 3,206.7 | 4,061,399.49 | 1,189,112.34 | 163,991.81 |
| 减:营业外支出 | 18,749.92 | 1,349,886.4 | 218,031.11 | 146,181.5 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 118,061,380.2 | 350,907,837.59 | 224,941,639.1 | 128,492,224.15 |
| 减:所得税费用 | 16,692,948.38 | 52,202,957.32 | 33,514,810.45 | 19,733,714.56 |
| 六、净利润 | 101,368,431.82 | 298,704,880.27 | 191,426,828.65 | 108,758,509.59 |
| 持续经营净利润 | 101,368,431.82 | 298,704,880.27 | 191,426,828.65 | 108,758,509.59 |
| 归属于母公司股东的净利润 | 101,369,815.9 | 299,796,292.39 | 192,274,739.14 | 109,432,033.43 |
| 少数股东损益 | -1,384.08 | -1,091,412.12 | -847,910.49 | -673,523.84 |
| (一)基本每股收益 | 1.49 | 4.64 | 3.03 | 1.76 |
| (二)稀释每股收益 | 1.49 | 4.64 | 3.03 | 1.76 |
| 九、综合收益总额 | 101,368,431.82 | 298,704,880.27 | 191,426,828.65 | 108,758,509.59 |
| 归属于母公司股东的综合收益总额 | 101,369,815.9 | 299,796,292.39 | 192,274,739.14 | 109,432,033.43 |
| 归属于少数股东的综合收益总额 | -1,384.08 | -1,091,412.12 | -847,910.49 | -673,523.84 |
| 公告日期 | 2024-04-22 | 2024-03-20 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |